{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T05:32:54Z","timestamp":1759815174228},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1992,11,1]],"date-time":"1992-11-01T00:00:00Z","timestamp":720576000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1992,11]]},"DOI":"10.1007\/bf02285087","type":"journal-article","created":{"date-parts":[[2006,1,25]],"date-time":"2006-01-25T18:36:58Z","timestamp":1138214218000},"page":"469-475","source":"Crossref","is-referenced-by-count":4,"title":["A comparative study of lisinopril and atenolol on low degree urinary albumin excretion, renal function and haemodynamics in uncomplicated, primary hypertension"],"prefix":"10.1007","volume":"43","author":[{"given":"O.","family":"Samuelsson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Hedner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ljungman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Herlitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Widgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Pennert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02285087_CR1","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1172\/JCI112528","volume":"77","author":"S Andersen","year":"1986","unstructured":"Andersen S, Rennke HG, Brenner BM (1986) Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 77:1993\u20132000","journal-title":"J Clin Invest"},{"key":"BF02285087_CR2","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1136\/bmj.300.6729.904","volume":"300","author":"S Bj\u00f6rck","year":"1990","unstructured":"Bj\u00f6rck S, Mulec H, Johnsen S-A, Nyberg G, Aurell M (1990) Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy. Br Med J 300: 904\u2013907","journal-title":"Br Med J"},{"issue":"Suppl 3","key":"BF02285087_CR3","doi-asserted-by":"crossref","first-page":"s43","DOI":"10.1097\/00005344-198700003-00011","volume":"9","author":"K Bolzano","year":"1987","unstructured":"Bolzano K et al. (1987) The antihypertensive effect of lisinopril compared to atenolol in patients with mild to moderate hypertension. J Cardiovascular Pharmacol 9 [Suppl 3]: s43-s45","journal-title":"J Cardiovascular Pharmacol"},{"key":"BF02285087_CR4","first-page":"F13","volume":"233","author":"MP Bohrer","year":"1977","unstructured":"Bohrer MP, Deen WM, Robertson CR, Brenner BM (1977) Mechanism of angiotensin II-proteinuria in the rat. Am J Physiol 233: F13-F21","journal-title":"Am J Physiol"},{"key":"BF02285087_CR5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/00365517609055255","volume":"36","author":"J Br\u00f8chner-Mortensen","year":"1976","unstructured":"Br\u00f8chner-Mortensen J, R\u00f8dbro P (1976) Comparison between total and renal plasma clearance of (51CR) EDTA. Scand J Clin Lab Invest 36:247\u2013249","journal-title":"Scand J Clin Lab Invest"},{"issue":"Suppl 3","key":"BF02285087_CR6","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1097\/00005344-198700003-00003","volume":"9","author":"HR Brunner","year":"1987","unstructured":"Brunner HR, Waeber B, Nussberger J (1987) Renal effects of converting enzyme inhibition. J Cardiovasc Pharmacol 9 [Suppl 3]: S6-S14","journal-title":"J Cardiovasc Pharmacol"},{"key":"BF02285087_CR7","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/bmj.300.6720.297","volume":"300","author":"EM Damsgaard","year":"1990","unstructured":"Damsgaard EM, Froland A, J\u00f8rgensen OD Mogensen CE (1990) Microalbuminuria as predictor of increased mortality in elderly people. Br Med J 300:297\u2013300","journal-title":"Br Med J"},{"key":"BF02285087_CR8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00285287","volume":"32","author":"T Deckert","year":"1989","unstructured":"Deckert T, Feldt-Rasmussen B, Borch-Johnsen K et al. (1989) Albuminuria reflects widespread vascular damage. The Steno hypothens. Diabetologia 32: 219\u2013226","journal-title":"Diabetologia"},{"key":"BF02285087_CR9","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1172\/JCI112377","volume":"77","author":"LD Dworkin","year":"1986","unstructured":"Dworkin LD, Feiner HD (1986) Glomerular injury in uninephrectomized spontaneously hypertensive rats. A consequence of glomerular capillary hypertension. J Clin Invest 77: 797\u2013809","journal-title":"J Clin Invest"},{"issue":"Suppl 2","key":"BF02285087_CR10","first-page":"143","volume":"3","author":"G Venuto De","year":"1985","unstructured":"De Venuto G, Andreotti C, Mattarei M, Pegoretti G (1985) Longterm captopril therapy at low doses reduces albumin excretion in patients with essential hypertension and no signs of renal impairment. J Hypertens 3 [Suppl 2]:143\u2013145","journal-title":"J Hypertens"},{"key":"BF02285087_CR11","first-page":"F526","volume":"244","author":"RM Edwards","year":"1983","unstructured":"Edwards RM (1983) Segmental effects of norepinephrine and angiotensin II on isolated renal microvessels. Am J Physiol 244: F526\u2013534","journal-title":"Am J Physiol"},{"key":"BF02285087_CR12","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1172\/JCI113590","volume":"82","author":"A Fogo","year":"1988","unstructured":"Fogo A, Yoshida Y, Glick AD, Hommer T, Ichikawa I (1988) Serial micropuncture analysis of glomerular function in two models of glomerulosclerosis. J Clin Invest 82: 322\u2013330","journal-title":"J Clin Invest"},{"key":"BF02285087_CR13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/ajh\/2.4.259","volume":"2","author":"S Giaconi","year":"1989","unstructured":"Giaconi S, Levand C, Fommei E, Innocenti F, Seghieri G, Palla L, Palombo C, Guione S (1989) Microalbuminuria and causal and ambulatory blood pressure monitoring in normotensives and in patients with borderline and mild essential hypertension. Am J Hypertens 2: 259\u2013261","journal-title":"Am J Hypertens"},{"key":"BF02285087_CR14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1042\/cs0760039","volume":"76","author":"D Gosling","year":"1989","unstructured":"Gosling D, Beevers DG (1989) Urinary albumin excretion and blood pressure in the general population. Clin Sci 76: 39\u201342","journal-title":"Clin Sci"},{"key":"BF02285087_CR15","first-page":"1431","volume":"45","author":"JE Hall","year":"1986","unstructured":"Hall JE (1986) Regulation of glomerular filtration rate and sodium excretion by angiotensin II. Fed Proc 45:1431\u20131437","journal-title":"Fed Proc"},{"key":"BF02285087_CR16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/ki.1987.174","volume":"32","author":"JE Heeg","year":"1987","unstructured":"Heeg JE, DeJong PE, van der Hem GK, de Zeeow D (1987) Reduction of proteinuria by angiotensin converting enzyme inhibition. Kidney Int 32:78\u201383","journal-title":"Kidney Int"},{"key":"BF02285087_CR17","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/00004872-198806000-00010","volume":"6","author":"B Jackson","year":"1988","unstructured":"Jackson B, Johnston C (1988) The contribution of systemic hypertension to progression of chronic renal failure in the rat remnant kidney: effect of treatment with an angiotensin converting enzyme inhibitor or a calcium inhibitor. J Hypertens 6: 495\u2013501","journal-title":"J Hypertens"},{"key":"BF02285087_CR18","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/0002-8703(84)90763-4","volume":"108","author":"WB Kannel","year":"1984","unstructured":"Kannel WB, Stampfer MJ, Castelli WP, Vester J (1984) The prognostic significance of proteinuria: the Framingham study. Am Heart J 108:1347\u20131352","journal-title":"Am Heart J"},{"key":"BF02285087_CR19","first-page":"15","volume-title":"Handbook of hypertension: epidemiology of hypertension","author":"WB Kannel","year":"1985","unstructured":"Kannel WB, Stokes J (1985) Hypertension as a cardiovascular risk factor. In: Bulpitt CJ (ed) Handbook of hypertension: epidemiology of hypertension. Science Publishers BV, Elsevier, Amsterdam, pp 15\u201334"},{"key":"BF02285087_CR20","first-page":"7","volume":"51","author":"YS Kanwar","year":"1984","unstructured":"Kanwar YS (1984) Biology of disease. Biophysiology of glomerular filtration and proteinuria. Lab Invest 51: 7\u201321","journal-title":"Lab Invest"},{"key":"BF02285087_CR21","first-page":"569","volume":"52","author":"M Kashgarian","year":"1985","unstructured":"Kashgarian M (1985) Mesangium and glomerular disease. Lab Invest 52:569\u2013571","journal-title":"Lab Invest"},{"key":"BF02285087_CR22","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1161\/01.HYP.15.5.443","volume":"15","author":"LB Kasiske","year":"1990","unstructured":"Kasiske LB, O'Donnel MP, Cowardin W, Keane WE (1990) Lipids and the kidney. Hypertens 15: 443\u2013450","journal-title":"Hypertens"},{"key":"BF02285087_CR23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000167599","volume":"8","author":"WF Keane","year":"1988","unstructured":"Keane WF, Kasiske BL, O'Donnel MP (1988) Lipids and progressive glomerulosclerosis. A model analogous to atherosclerosis. Am J Nephrol 8:261\u2013271","journal-title":"Am J Nephrol"},{"key":"BF02285087_CR24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.0954-6820.1980.tb01144.x","volume":"208","author":"S Ljungman","year":"1980","unstructured":"Ljungman S, Aurell M, Hartford M, Wikstrand J, Wilhelmsen L, Berglund G (1980) Blood pressure and renal function. Acta Med Scand 208:17\u201325","journal-title":"Acta Med Scand"},{"key":"BF02285087_CR25","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/ajh\/3.12.956","volume":"3","author":"S Ljungman","year":"1990","unstructured":"Ljungman S (1990) The role of microalbuminuria in essential hypertension. Am J Hypertens 3: 956\u2013960","journal-title":"Am J Hypertens"},{"key":"BF02285087_CR26","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1136\/bmj.294.6585.1448","volume":"294","author":"M Marre","year":"1987","unstructured":"Marre M, LeBlanc H, Suarez L, Guyenne TT, Menard J, Passa P (1987) Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria Br Med J 294:1448\u20131452","journal-title":"Br Med J"},{"key":"BF02285087_CR27","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/BF00395552","volume":"31","author":"MB Mattock","year":"1988","unstructured":"Mattock MB Keen H, Viberti GC, El-Gohari MR, Murrels TJ, Scott GS, Wing JR, Jackson PG (1988) Coronary heart disease and urinary albumin excretion rate in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 31: 82\u201387","journal-title":"Diabetologia"},{"key":"BF02285087_CR28","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/00004872-198811000-00011","volume":"6","author":"A Mimran","year":"1988","unstructured":"Mimran A, Insua A, Ribenstein J, Monnier L, Bringer J, Mirouce J (1988) Contrasting effects of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy. J Hypertension 6: 919\u2013923","journal-title":"J Hypertension"},{"key":"BF02285087_CR29","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1056\/NEJM198402093100605","volume":"310","author":"CE Mogensen","year":"1984","unstructured":"Mogensen CE (1984) Microalbuminuria products clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310:356\u2013360","journal-title":"N Engl J Med"},{"key":"BF02285087_CR30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000183064","volume":"35","author":"B Montagna","year":"1983","unstructured":"Montagna B, Buzio C, Calderini C, Quaretti P, Migone L (1983) Relationship of proteinuria and albuminuria to posture and urine collection period. Nephron 35: 143\u2013144","journal-title":"Nephron"},{"key":"BF02285087_CR31","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2337\/diacare.39.1.76","volume":"39","author":"E Morelli","year":"1990","unstructured":"Morelli E (1990) Effects of converting enzyme inhibition on barrier function in diabetic glomerulopathy. Diabetes 39: 76\u201382","journal-title":"Diabetes"},{"key":"BF02285087_CR32","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1136\/bmj.294.6585.1443","volume":"294","author":"HH Parving","year":"1987","unstructured":"Parving HH, Andersen AR, Smidt UM, Hommel E, Mathiesen ER, Svendsen PAA (1987) Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J 294: 1443\u20131447","journal-title":"Br Med J"},{"key":"BF02285087_CR33","first-page":"643","volume":"32","author":"HH Parving","year":"1973","unstructured":"Parving HH, Gyntelberg F (1973) Transcapillary escape rate of albumin and plasma volume in essential hypertension. Clin Res 32: 643\u2013651","journal-title":"Clin Res"},{"key":"BF02285087_CR34","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/00365517709091486","volume":"37","author":"HH Parving","year":"1977","unstructured":"Parving HH, Jensen HA, Westrup M (1977) Increased transcapfllary escape rate of albumin and IgG in essential hypertension. Scand J Lab Invest 37:223\u2013227","journal-title":"Scand J Lab Invest"},{"key":"BF02285087_CR35","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/S0140-6736(74)91002-2","volume":"1","author":"HH Parving","year":"1974","unstructured":"Parving HH, Jensen MA, Mogensen CE (1974) Increased urinary albumin rate in benign essential hypertension. Lancet 1: 1190\u20131192","journal-title":"Lancet"},{"key":"BF02285087_CR36","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/00365517609055253","volume":"36","author":"EB Pedersen","year":"1976","unstructured":"Pedersen EB, Mogensen CE (1976) Effects of antihypertensive treatment on urinary albumin excretion, glomerular filtration rate, and renal plasma flow inpatients with essential hypertension. Scand J Lab Invest 36: 231\u2013237","journal-title":"Scand J Lab Invest"},{"issue":"Suppl 3C","key":"BF02285087_CR37","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/0002-9343(85)90076-2","volume":"79","author":"L Raij","year":"1985","unstructured":"Raij L, Keane WF (1985) Glomerular mesangium: its function and relationship to angiotensin II. Am J Med 79 [Suppl 3C]: 24\u201330","journal-title":"Am J Med"},{"issue":"Suppl 6","key":"BF02285087_CR38","doi-asserted-by":"crossref","first-page":"S312","DOI":"10.1097\/00004872-198900076-00152","volume":"6","author":"G Romanelli","year":"1989","unstructured":"Romanelli G, Giustina A, Agabiti-Rosei E, Bossoni S, Girelli A, Muiesan ML, Muiesan G, Giustina G (1989) Short-term effect of captopril and nifedipine on microalbuminuria induced by exercise in hypertensive diabetic patients. J Hypertens 6 [Suppl 6]: S312-S313","journal-title":"J Hypertens"},{"issue":"Suppl 4","key":"BF02285087_CR39","doi-asserted-by":"crossref","first-page":"S467","DOI":"10.1097\/00004872-198812040-00147","volume":"6","author":"LM Ruilope","year":"1988","unstructured":"Ruilope LM, Miranda B, Oliet A, Millet VG, Rodicio JL, Romero JC, Raij L (1988) Control of hypertension with the angiotensin converting enzyme inhibitor captopril reduces glomerular proteinuria. J Hypertension 6 [Suppl 4]: S467-S469","journal-title":"J Hypertension"},{"issue":"Suppl 3","key":"BF02285087_CR40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2165\/00003495-198800363-00005","volume":"36","author":"O Samuelsson","year":"1988","unstructured":"Samuelsson O (1988) Experiences from hypertension trials. Impact of other risk factors. Drugs 36 [Suppl 3]: 9\u201320","journal-title":"Drugs"},{"issue":"Suppl 5","key":"BF02285087_CR41","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2165\/00003495-198800355-00008","volume":"35","author":"O Samuelsson","year":"1988","unstructured":"Samuelsson O (1988) Proteinuria as a prognostic factor during longterm antihypertensive care. Drugs 35 [Suppl 5]: 48\u201354","journal-title":"Drugs"},{"key":"BF02285087_CR42","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0140-6736(88)92504-4","volume":"II","author":"CP Shearman","year":"1988","unstructured":"Shearman CP, Gosling P (1988) Microalbuminuria and vascular permeability. Lancet II: 906\u2013907","journal-title":"Lancet"},{"key":"BF02285087_CR43","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/S0140-6736(82)92450-3","volume":"1","author":"GC Viberti","year":"1982","unstructured":"Viberti GC, Hill RD, Jarret RJ, Argyrpados A, Mahmud U, Keen H (1982) Microalbuminuria as predictor of clinical nephropathy in insulin-depent diabetes mellitus. Lancet 1: 1430\u20131432","journal-title":"Lancet"},{"key":"BF02285087_CR44","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1532-5415.1980.tb00243.x","volume":"28","author":"T Yamada","year":"1980","unstructured":"Yamada T, Ishiara M, Ishikawa K, Hiramoto K (1980) Protenuria and renal function during antihypertensive treatment for essential hypertension. J Am Geriatries Soc 28:114\u2013117","journal-title":"J Am Geriatries Soc"},{"key":"BF02285087_CR45","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0140-6736(88)92657-8","volume":"II","author":"JS Yudkin","year":"1988","unstructured":"Yudkin JS, Forrest RD, Jackson CA (1988) Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Lancet II: 530\u2013533","journal-title":"Lancet"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02285087.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02285087\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02285087","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T18:45:06Z","timestamp":1557945906000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02285087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,11]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1992,11]]}},"alternative-id":["BF02285087"],"URL":"https:\/\/doi.org\/10.1007\/bf02285087","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,11]]}}}